” European biotech may, because of detrimental plans from the United States federal government, be a lot more appealing for financiers to purchase,” claims the pharmaceutical firm’s chairman, Martin Nicklasson.
发布者:BY JENS STAVNSBJERG,转转请注明出处:https://robotalks.cn/zealand-pharma-chair-sees-potential-in-us-healthcare-cuts/